Mägi R

No ORCID on file · 6 papers in corpus · active 2015-2026

Study types

  • article 1

Condition tags

  • endometriosis 1
  • irritable_bowel_syndrome 1
  • infertility 1
2026
PLoS medicine ·doi:10.1371/journal.pmed.1005086

BackgroundHormonal contraceptives (HCs) are widely used and have well-documented population-level statistics. Previous studies with short follow-ups have focussed on individual HC use and side effects. However, the same aspects over longer …

2025
·doi:10.1101/2025.08.15.25333767

Importance Hormonal contraceptives (HCs) support reproductive goals and alleviate symptoms of gynaecological conditions for millions of women. Despite widespread use, individual long-term HC use trends, medication switching, and impact of …

2024
·doi:10.1101/2024.01.29.24301773

STUDY QUESTION Can a large-scale genome-wide association study (GWAS) meta-analysis identify the genomic risk loci and associated candidate genes for female genital tract (FGT) polyps, provide insights into the mechanism underlying their de…

2023
·doi:10.1101/2023.07.31.23293408

ABSTRACT Background Copy-number variations (CNVs) have been associated with rare and debilitating genomic syndromes but their impact on health later in life in the general population remains poorly described. Methods Assessing four modes of…

article 2022
Human Reproduction ·doi:10.1093/humrep/deac140

STUDY QUESTION: Do the spectrum and prevalence of comorbidities of endometriosis and irritable bowel syndrome (IBS) overlap? SUMMARY ANSWER: Despite several overlapping symptoms, the most significantly associated comorbidities of endometri…

2015
Nature ·doi:10.1038/nature14132

Body fat distribution is a heritable trait and a well-established predictor of adverse metabolic outcomes, independent of overall adiposity. To increase our understanding of the genetic basis of body fat distribution and its molecular links…